![]() ![]() What we did then was we raised €1.3 million, which has gotten us to today. Phase two is deploy it wherever you can, and then it's just a race to product market fit. That's kind of phase one – get enough money in so that you can build something that's deployable. We went out and worked with a third party called Threadable, who are based in Dogpatch Labs, and they built it for us. So they brought me in, and it also funded the build of our first version of our clinical decisions platform. The founders were working on it on a part-time basis and really, you need somebody to come in full time to take the lead on it. That early funding enabled them to hire me. That's obviously a good resource of early funding. The 'pre' pre-seed round would have been around €600,000.Īgain, it was primarily friends or family and colleagues, particularly medical professionals who work in that space, because they want to fund the solutions that are going to make their day to day better. The earliest round was a friends and family round to get things started. Why not share your own funding story with Enterprise Nation? Where did xWave's finance journey begin? Here, Mitchell tells Enterprise Nation's Fiona Alston about xWave's funding story to date and his business consultant expertise. Their xRefer solution is a cloud-based clinical decision support system to help radiology teams in vetting referrals more efficiently.Īs part of Enterprise Nation's Access to Finance programme, we've been asking business founders to tell us about their experiences of getting funding. XWave was founded in 2020 by a team of radiologists who wanted to create intelligent solutions for the problems they were facing daily at work. ![]() xWave is on a mission to save lives by ensuring that patients get the best tests first. ![]() Mitchell O’Gorman is the CEO of xWave Technologies. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |